Synopsys, Inc. (NASDAQ:SNPS – Get Free Report) insider Aart de Geus sold 25,000 shares of the business’s stock in a transaction on Monday, August 31st. The stock was sold at an average price of $441.76, for a total value of $11,044,000.00. Following the transaction, the insider directly owned 120,421 shares of the company’s stock, valued at $53,197,180.96. The trade was a 17.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Geus Aart De also recently made the following trade(s):
- On Tuesday, September 1st, Aart de Geus sold 24,641 shares of Synopsys stock. The shares were sold at an average price of $419.44, for a total transaction of $10,335,421.04.
- On Friday, August 28th, Aart de Geus sold 25,000 shares of Synopsys stock. The shares were sold at an average price of $445.55, for a total transaction of $11,138,750.00.
Synopsys Trading Down 5.4%
NASDAQ:SNPS opened at $393.84 on Friday. Synopsys, Inc. has a 52-week low of $366.00 and a 52-week high of $615.79. The company has a market capitalization of $75.48 billion, a PE ratio of 69.58, a P/E/G ratio of 2.28 and a beta of 1.23. The stock’s 50 day moving average price is $412.27 and its 200 day moving average price is $439.47. The company has a quick ratio of 1.24, a current ratio of 1.34 and a debt-to-equity ratio of 0.29.
Trending Headlines about Synopsys
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Synopsys reported fiscal third-quarter revenue of approximately $2.48 billion and non-GAAP EPS of $3.91, exceeding analyst estimates of $2.44 billion and $3.67, respectively. Revenue grew 42.4% year over year, underscoring continued demand for electronic-design automation and semiconductor IP. Synopsys Results Analysis
- Positive Sentiment: Analysts continue to see significant long-term upside, with reported price targets generally ranging from $450 to $610 and a consensus “Moderate Buy” rating. The bullish case centers on Synopsys’ strategic importance to advanced chip and AI design. Synopsys Wall Street Price Targets
- Neutral Sentiment: Institutional positioning is mixed: 769 investors added SNPS shares in their latest reported quarter, while 764 reduced positions. This suggests continued interest but limited consensus among large investors. Synopsys Institutional Activity
- Negative Sentiment: The earnings beat did not translate into a sufficiently large outlook increase for a stock priced for stronger growth. Full-year guidance implies approximately $9.715 billion of revenue and $15.07 of non-GAAP EPS at the midpoint, prompting a potential “sell-the-news” reaction.
- Negative Sentiment: Investors remain concerned about execution and margin pressure from the Ansys integration. Synopsys reported roughly $236.3 million in restructuring charges during the first nine months of fiscal 2026, while acquired-intangible amortization and approximately $10 billion of debt add to acquisition-related financial risks. Synopsys Ansys Integration Analysis
- Negative Sentiment: Executive Chair Aart de Geus sold 49,641 shares for approximately $21.4 million across August 28, August 31 and September 1. The transactions were made under a pre-arranged Rule 10b5-1 plan, reducing their value as a discretionary bearish signal, but the selling may still weigh on sentiment. Synopsys Insider Selling
- Negative Sentiment: SNPS remains sensitive to higher interest rates and semiconductor-sector weakness. Its valuation remains demanding, with a reported P/E ratio above 69, while the stock is trading below its 200-day moving average. Is Synopsys Stock Underperforming the Nasdaq?
Institutional Investors Weigh In On Synopsys
Several large investors have recently modified their holdings of the stock. BlackRock Inc. bought a new stake in Synopsys during the 2nd quarter worth approximately $7,228,099,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in Synopsys in the second quarter valued at approximately $747,400,000. Norges Bank acquired a new position in shares of Synopsys during the 4th quarter worth about $730,197,000. Bank of New York Mellon Corp bought a new stake in shares of Synopsys in the second quarter worth about $692,074,000. Finally, State Street Corp raised its position in shares of Synopsys by 20.6% during the third quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company’s stock worth $4,322,273,000 after purchasing an additional 1,493,912 shares during the period. 85.47% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several analysts have recently issued reports on the stock. Zacks Research cut shares of Synopsys from a “strong-buy” rating to a “hold” rating in a research note on Friday, August 21st. Morgan Stanley dropped their target price on shares of Synopsys from $525.00 to $500.00 and set an “equal weight” rating for the company in a research report on Wednesday, August 19th. KeyCorp reaffirmed an “overweight” rating on shares of Synopsys in a report on Wednesday, August 19th. Robert W. Baird upgraded shares of Synopsys from a “neutral” rating to an “outperform” rating and raised their price target for the company from $558.00 to $560.00 in a research note on Thursday, August 27th. Finally, Rosenblatt Securities reissued a “buy” rating and set a $575.00 target price on shares of Synopsys in a report on Tuesday, August 25th. Twelve research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $561.28.
View Our Latest Stock Report on Synopsys
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
